Sildenafil For Suspension
Product Images NDC 31722-136

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 31722-136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo1 (Camberlogo1)

FDA Label Image

Camberlogo2 (Camberlogo2)

FDA Label Image

Sildenafiloscontcarton (Sildenafiloscontcarton)

Sildenafiloscontcarton (Sildenafiloscontcarton)
This is a description for a medication called Sildenafil. It is a medication to be taken orally and is available in a grape flavor. The medication comes in a powder form that requires reconstitution by adding 12mL of liquid. A prescription is required to purchase the medication. There is also some unclear text and images, such as batch coding information, an unvarnished area, and additional text not legible by .*
FDA Label Image

Sildenafilosfig1 (Sildenafilosfig1)

FDA Label Image

Sildenafilosfig10 (Sildenafilosfig10)

Sildenafilosfig10 (Sildenafilosfig10)
This appears to be a table of clinical trial results for Sildenafil, which is a medication used to treat pulmonary arterial hypertension. The table may be showing the baseline distance walked and changes in walking distance for patients with idiopathic or CTD-associated PAH after taking a dose of 20mg sildenafil three times daily. The table shows mean values for various parameters, including PAP, PVRI and change in 6-minute walk distance.*
FDA Label Image

Sildenafilosfig11 (Sildenafilosfig11)

FDA Label Image

Sildenafilosfig12 (Sildenafilosfig12)

FDA Label Image

Sildenafilosfig2 (Sildenafilosfig2)

FDA Label Image

Sildenafilosfig3 (Sildenafilosfig3)

FDA Label Image

Sildenafilosfig4 (Sildenafilosfig4)

FDA Label Image

Sildenafilosfig5 (Sildenafilosfig5)

FDA Label Image

Sildenafilosfig6 (Sildenafilosfig6)

FDA Label Image

Sildenafilosfig7 (Sildenafilosfig7)

Sildenafilosfig7 (Sildenafilosfig7)
This text seems to be a table related to the interaction of different drugs with each other. It provides information on the recommended dose adjustment and accumulation ratios for different drugs such as Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maaloxe, Oral Contraceptives, Ritonavir and Saquinavir. It also presents the Fold Change and 90% CI for the drugs in the table along with a recommendation for each of the drugs.*
FDA Label Image

Sildenafilosfig8 (Sildenafilosfig8)

Sildenafilosfig8 (Sildenafilosfig8)
This is a table of drugs and their corresponding information regarding dose adjustment, and interaction with other drugs. It includes data on the INR (International Normalized Ratio) and AUC (Area Under the Curve) for each drug. Some drugs require dose adjustment when interacting with other drugs, while others do not. There is also a chart that shows the relative change in interacting drugs to when they are taken alone.*
FDA Label Image

Sildenafilosfig9 (Sildenafilosfig9)

FDA Label Image

Sildenafilosfiga (Sildenafilosfiga)

FDA Label Image

Sildenafilosfigb (Sildenafilosfigb)

FDA Label Image

Sildenafilosfigc (Sildenafilosfigc)

FDA Label Image

Sildenafilosfigd (Sildenafilosfigd)

FDA Label Image

Sildenafilosfige (Sildenafilosfige)

FDA Label Image

Sildenafilosfigf (Sildenafilosfigf)

FDA Label Image

Sildenafilosfigg (Sildenafilosfigg)

FDA Label Image

Sildenafilosstructure (Sildenafilosstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.